UK markets close in 8 hours 24 minutes

BB Biotech AG (0JYO.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
58.54-0.41 (-0.70%)
As of 05:11PM BST. Market open.
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-17.07%
S&P500 52-week change 328.04%
52-week high 360.70
52-week low 338.65
50-day moving average 342.28
200-day moving average 348.61

Share statistics

Avg vol (3-month) 36.52k
Avg vol (10-day) 37.53k
Shares outstanding 555.4M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 11.76%
% held by institutions 110.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.00
Trailing annual dividend yield 33.39%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 329 Mar 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 113.66%
Operating margin (ttm)96.77%

Management effectiveness

Return on assets (ttm)5.47%
Return on equity (ttm)12.96%

Income statement

Revenue (ttm)270.74M
Revenue per share (ttm)4.94
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)307.74M
Diluted EPS (ttm)-16.73
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.82B
Total cash per share (mrq)51.46
Total debt (mrq)344.7M
Total debt/equity (mrq)13.93%
Current ratio (mrq)7.99
Book value per share (mrq)45.11

Cash flow statement

Operating cash flow (ttm)86.44M
Levered free cash flow (ttm)144.83M